Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akinori Ebihara is active.

Publication


Featured researches published by Akinori Ebihara.


COPD: Journal of Chronic Obstructive Pulmonary Disease | 2005

Sleep Disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease

Takuya Aoki; Akinori Ebihara; Yurika Yogo; Fumio Sakamaki; Yukio Suzuki; Keiichi Suemasu

Sleep-related disordered breathing (SDB) and its influence on desaturation were examined in stable COPD patients with waking SpO2 > 90%. With respiratory inductance plethysmography, thoracic-abdominal respiratory movements for all events with more than 4% desaturation were analyzed in 26 patients. Types of SDB were confirmed by full polysomnography. Irregular breathing induced desaturation, while stable respiration continued during some desaturation events. Three types of altered ventilation were observed: hypoventilation, paradoxical movement and periodic breathing. An unusual type of paradoxical movement, with normal airflow despite progressive desaturation, was observed in REM sleep. Patients were divided into desaturation (15 patients) and non-desaturation (11 patients) groups. Daytime arterial blood gas, lung function values, and 6-min walking distance did not differ. Awake, mode, maximum and minimum nocturnal SpO2 were lower in the desaturation group. SDB-induced desaturation events in the desaturation group were more frequent (9.2 ± 3.5 vs. 1.8 ± 2.2 times), a greater SpO2 decrease (11.4 ± 7.1% vs. 5.2 ± 2.1%) and longer duration (73.2 ± 34.8 vs. 18.8 ± 39.0 min). Patterns of SDB in the desaturation group were hypoventilation (74.4 ± 23.4%), paradoxical movement (10.2 ± 14.5%), periodic breathing (12.1 ± 18.3%) and unclassified (5.8 ± 11.2%). These results reveal that lower SpO2 and SDB influence nocturnal desaturation in stable COPD patients.


Surgery Today | 2006

Isolated unilateral absence of a pulmonary artery treated by pneumonectomy in an adult: Report of a case

Takashi Ohtsuka; Hiroaki Nomori; Kenichi Watanabe; Masahiro Kaji; Akinori Ebihara; Tsuguo Naruke; Keiichi Suemasu

Congenital unilateral absence of a pulmonary artery (UAPA) is a rare anomaly usually diagnosed in childhood. We report a case of isolated UAPA in an adult without any other cardiovascular anomaly. The patient was admitted for repeated progressive hemoptysis, which we treated with embolization of the bronchial artery three times, despite which the hemoptysis kept recurring. Finally, the patient was treated successfully by right pneumonectomy. Thus, we think that surgical intervention is indicated for recurrent hemoptysis in patients with isolated UAPA.


Oncology Letters | 2014

Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer.

Takuya Aoki; Akinori Ebihara; Yurika Yogo; Keiichi Suemasu; Fumio Sakamaki

The present study aimed to analyze the efficacy and safety of multiple cycles of docetaxel and carboplatin (CBDCA) as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC). Patients with stage III or IV NSCLC, whose treatment began between July 1999 and February 2003, were retrospectively evaluated. Relatively low doses of docetaxel and CBDCA were administered for as many cycles as possible. The primary outcome assessed was the overall survival (OS) time, and the secondary outcomes included progression-free survival (PFS) time, response rate (RR) and adverse events. The median cycle number was four (range, 2–12). The median OS time was 400 days, and for adenocarcinoma and non-adenocarcinoma, the OS time was 490 and 192 days, respectively. The median PFS time was 176 days and the RR was 66.7%. The main toxicity of the treatment was neutropenia, with grade 3 or 4 neutropenia occurring in 81.0% of patients. Continuous first-line treatment with this regimen may have encouraging effects within a certain group of advanced NSCLC patients, thereby warranting further investigations.


Respiratory Physiology & Neurobiology | 2015

Hypobaric hypoxia is not a direct dyspnogenic factor in healthy individuals at rest

Takayuki Nakano; Masayuki Iwazaki; Gen Sasao; Asuka Nagai; Akinori Ebihara; Tokuzen Iwamoto; Ichiro Kuwahira

Dyspnea consists of various uncomfortable respiratory sensations. It is believed that hypoxia causes dyspnea, but whether hypoxia is a direct dyspnogenic factor remains uncertain. We investigated whether hypoxia has a direct dyspnogenic effect. We evaluated changes in vital signs, arterial blood gases, SaO2, CaO2, Borg scale, and Mini-Mental State Examination in seven mountain climbers by using a hypobaric hypoxic chamber in which the barometric pressure was lowered to the simulated altitude of 4500 m. PaO2 and CaO2 both decreased significantly as the simulated altitude increased. On the other hand, Borg scale score which reflects dyspnea showed no significant difference. At the simulated altitude of 4500 m, Borg scale score was 1.5 ± 1.2 (mean ± SD), despite the presence of absolute hypoxia (PaO2, 46.8 ± 8.3T; CaO2, 16.4 ± 0.6 mL/dL). These results suggest that hypoxia is not a direct dyspnogenic factor in healthy individuals capable of breathing without restriction at rest.


Chest | 2018

A 48-Year-Old Man With Multiple Pulmonary Nodular Opacities and Elevated KL-6 Level

Takayuki Nakano; Ichiro Kuwahira; Hidenobu Shigemitsu; Tomoki Nakagawa; Asuka Nagai; Akinori Ebihara; Teruaki Oka; Masayuki Iwazaki

CASE PRESENTATION A 48-year-old man was referred for evaluation of an abnormal chest shadow noted on a routine chest radiograph during physical examination. He was asymptomatic and had no significant medical history and occupational exposure. The patient lived in Tokyo and had no significant travel history. He had smoked approximately 20 cigarettes daily for 20 years. He had no illicit drug use and no animal-rearing history.


Japanese Journal of Clinical Oncology | 2006

[F-18]Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA Lung Adenocarcinomas

Kenichi Watanabe; Hiroaki Nomori; Takashi Ohtsuka; Tsuguo Naruke; Akinori Ebihara; Hideki Orikasa; Kazuto Yamazaki; Kimiichi Uno; Toshiaki Kobayashi; Tomoyuki Goya


Annals of Thoracic and Cardiovascular Surgery | 2006

FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Takashi Ohtsuka; Hiroaki Nomori; Akinori Ebihara; Kenichi Watanabe; Masahiro Kaji; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno


Japanese Journal of Clinical Oncology | 2006

Characteristics of Advantages of Positron Emission Tomography over Computed Tomography for N-staging in Lung Cancer Patients

Akinori Ebihara; Hiroaki Nomori; Kenichi Watanabe; Takashi Ohtsuka; Tsuguo Naruke; Kimiichi Uno; Ichiro Kuwahira; Kenji Eguchi


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2004

Superior Sulcus Lung Cancer Invading the Ribs and Brachial Plexus Successfully Resected by Modified Trap-door Thoracotomy after Induction Chemoradiotherapy

Takashi Ohtsuka; Hiroaki Nomori; Hirotoshi Horio; Akinori Ebihara; Tsuguo Naruke; Keiichi Suemasu


日本臨床生理学会雑誌 = Japanese journal of applied physiology | 2011

Reproducibility of Arterial Blood Gases Determined under Hypobaric Hypoxia in Japanese Himalayan Climbers

Gen Sasao; Tokuzen Iwamoto; Asuka Nagai; Takayuki Nakano; Akinori Ebihara; Ichiro Kuwahira

Collaboration


Dive into the Akinori Ebihara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge